Skip to main content

Table 1 Demographics of multiple courses lung SBRT patients

From: Outcomes of Stereotactic Body Radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules

Gender N=63
Male 29
Female 34
Median age at tx 72 (range 20-90)
Histology N=63
Breast cancer 1
Head & neck 5
Non small cell lung cancer 40
Small cell lung cancer 1
Melanoma 4
Renal cell carcinoma 2
Skin cancer 1
Colon ca 6
Thyroid 1
Sarcoma 2
Prior definitive lung external beam radiotherapy N=63
Yes 18
No 45
Central vs peripheral lesion N=128
Central 47
Peripheral 81
Mean tumour diameter (longest dimension) N=128
  1.8 cm (range 0.6 to 5.0 cm)
Primary v recurrent v metastatic disease N=128
Primary lung tumour 40
Recurrence after primary SBRT for T1N0 disease 25
Metastatic lung nodules 45
Recurrence after EBRT for locally advanced lung cancer 15
Unknown 3
Prescription dose N=128
40 Gy/5# 3
45 Gy/9# 1
45 Gy/5# 1
48 Gy/4# 30
50 Gy/10# 2
50 Gy/5# 43
54 Gy/3# 43
57.5 Gy/5# 1
60 Gy/3# 5
Number of sites treated per patient N=63
1 12
2 42
3 6
4 3
Number of SBRT courses per patient N=63
1 (synchronous; 2 sites treated at once) 29
2 28
3 6
Response to treatment (based on imaging) N=128
CR 21
PR 63
Progression 3
SD 26
Unknown 16
Chemo given N=63
Yes 17
No 46